Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Industry News

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

September 02, 2020

News Industry News

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

February 25, 2020

News Industry News

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

September 12, 2019

News Industry News

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

July 16, 2019

News Industry News

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

July 15, 2019

News Industry News

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

July 01, 2019

News Industry News

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

May 06, 2019

News Industry News

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

April 26, 2019

News Industry News

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

April 17, 2019

News Industry News

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

January 24, 2018

News Industry News

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

July 20, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

News Industry News

LivaNova Acquires Caisson Interventional, LLC

May 02, 2017

News Industry News

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

July 13, 2016

News Industry News

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

February 21, 2016

News Industry News

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

October 16, 2015

News Industry News

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

October 12, 2015

News Industry News

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

October 11, 2015

News Industry News

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

October 08, 2015

News Industry News

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

October 05, 2015

Advertisement

Cardiac Dimensions Announces Australian Therapeutic Goods Administration's Approval of the Carillon System for the Treatment of Functional Mitral Regurgitation

New Data Confirms Cardiac Dimensions’ Carillon® System Shows Favorable Long-Term Survival Rate In Patients With Functional Mitral Regurgitation

Reduce Fmr Study Shows Cardiac Dimensions’ Carillon® System Significantly Improves Mitral Regurgitation And Slows Worsening Of Heart Failure

Neovasc Provides Further Update on Reducer™ Program for Treatment of Refractory Angina

Abbott Receives U.S. Approval Of Next-Generation Mitraclip™, Bringing New Enhancements To Abbott's Leading Mitraclip Platform

Cardiac Dimensions Reaches 1,000 Implants Of Carillon® System, A Minimally Invasive Treatment For Functional Mitral Regurgitation

Neovasc Announces Treatment of 1,000th Refractory Angina Patient with Neovasc Reducer™

New Data Confirms Cardiac Dimensions' Carillon® System Provides Acute Hemodynamic Efficacy In Patients With Functional Mitral Regurgitation

Neovasc Announces Peer Reviewed Publication in the International Journal of Cardiology Demonstrating that the Neovasc Reducer™ Improves Diastolic Function in patients suffering from severe angina

Boston Scientific Announces Investment and Acquisition Option Agreement with Millipede, Inc.

4C Medical Exceeds $8 Million Convertible Note Financing Round Led by Anges Québec

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

LivaNova Acquires Caisson Interventional, LLC

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

Mitralign Percutaneous Annuloplasty System Earns CE Mark Approval for Functional Mitral Regurgitation

Neovasc Tiara™ Featured in Live Case Session at TCT 2015 Scientific Symposium

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting

Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies

MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content